Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Eugene K. Lee

Urology
The University of Kansas Health System
Kansas University Physicians Inc
20333 W 151st St, Olathe Medical Center, 
Olathe, KS 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
The University of Kansas Health System
Kansas University Physicians Inc
20333 W 151st St, Olathe Medical Center, 
Olathe, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eugene Lee is an Urologist in Olathe, Kansas. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Lee is currently accepting new patients.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in KS
Hospital Affiliations
University Of Kansas Hospital
Mosaic Life Care At St Joseph
Cameron Regional Medical Center
Stormont Vail Hospital
Languages Spoken
English
Korean
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

KANSAS UNIVERSITY PHYSICIANS INC
20333 W 151st St, Olathe Medical Center, Olathe, KS 66061
Call: 913-588-1227
Other Locations
KANSAS UNIVERSITY PHYSICIANS INC
4000 Cambridge St, Suite G600, Kansas City, KS 66160
Call: 913-588-1227
KANSAS UNIVERSITY PHYSICIANS INC
3901 Rainbow Blvd, Kansas City, KS 66160
Call: 913-588-7013
KANSAS UNIVERSITY PHYSICIANS INC
2650 Shawnee Mission Pkwy, Westwood, KS 66205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
Blue Light Cystoscopy With Cysview® Registry
Blue Light Cystoscopy With Cysview® Registry
Enrollment Status: Recruiting
Publish Date: August 22, 2025
Intervention Type: Device, Drug
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: ALT-803, Bacillus Calumette-Guerin
Study Phase: Phase 2/Phase 3
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)
Enrollment Status: Active_not_recruiting
Publish Date: July 03, 2025
Intervention Type: Other, Biological
Study Drugs: CG0070, N-Dodecyl-B-D-Maltoside
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Enrollment Status: Active_not_recruiting
Publish Date: February 21, 2025
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

48 Total Publications

Less Is More: Going Green in Urological Procedures.
Less Is More: Going Green in Urological Procedures.
Journal: Urology practice
Published: July 25, 2025
View All 48 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. David A. Duchene
Urology | General Surgery
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. David A. Duchene
Urology | General Surgery

Kansas University Physicians Inc

4000 Cambridge St, 
Kansas City, KS 
 (18.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Duchene is an Urologist and a General Surgeon in Kansas City, Kansas. Dr. Duchene is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Ureteroscopy, and Nephrectomy. Dr. Duchene is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Moben M. Mirza
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Moben M. Mirza
Urology

Kansas University Physicians Inc

20333 W 151st St, Olathe Medical Center, 
Olathe, KS 
 (0.1 miles away)
913-588-1227
Languages Spoken:
English, Hindi, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Moben Mirza is an Urologist in Olathe, Kansas. Dr. Mirza is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Wilms Tumor, Familial Wilms Tumor 2, Reconstructive Urology Surgery, and Nephrectomy. Dr. Mirza is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jeffrey M. Holzbeierlein
Urology | General Surgery
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jeffrey M. Holzbeierlein
Urology | General Surgery

Kansas University Physicians Inc

2650 Shawnee Mission Pkwy, 
Westwood, KS 
 (16.7 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Holzbeierlein is an Urologist and a General Surgeon in Westwood, Kansas. Dr. Holzbeierlein is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Holzbeierlein is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lee's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Lee is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Distinguished
  • Chromophobe Renal Cell Carcinoma
    Dr. Lee is
    Distinguished
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Lee is
    Distinguished
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Cystectomy
    Dr. Lee is
    Distinguished
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Familial Wilms Tumor 2
    Dr. Lee is
    Distinguished
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Muscle Invasive Bladder Cancer
    Dr. Lee is
    Distinguished
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Lee is
    Distinguished
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
View All 12 Distinguished Conditions
  • Advanced
  • Bilateral Hydronephrosis
    Dr. Lee is
    Advanced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Boils
    Dr. Lee is
    Advanced
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Lee is
    Advanced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Empyema
    Dr. Lee is
    Advanced
    . Learn about Empyema.
    See more Empyema experts
  • Familial Prostate Cancer
    Dr. Lee is
    Advanced
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Folliculitis
    Dr. Lee is
    Advanced
    . Learn about Folliculitis.
    See more Folliculitis experts
View All 18 Advanced Conditions
  • Experienced
  • Balanitis
    Dr. Lee is
    Experienced
    . Learn about Balanitis.
    See more Balanitis experts
  • Bladder Outlet Obstruction
    Dr. Lee is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bladder Reconstruction
    Dr. Lee is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Bladder Stones
    Dr. Lee is
    Experienced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Congenital Mesoblastic Nephroma
    Dr. Lee is
    Experienced
    . Learn about Congenital Mesoblastic Nephroma.
    See more Congenital Mesoblastic Nephroma experts
  • Enlarged Prostate (BPH)
    Dr. Lee is
    Experienced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved